Palatin Technologies
PTN
#9923
Rank
HK$0.30 B
Marketcap
HK$179.05
Share price
4.59%
Change (1 day)
2,457.14%
Change (1 year)

Revenue for Palatin Technologies (PTN)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of HK$2.71 Million a decrease over the revenue in the year 2023 that were of HK$55.43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 HK$2.71 M-95.1%
2023 HK$55.43 M146.1%
2022 HK$22.52 M287.46%
2021 HK$5.81 M-265.72%
2020 -HK$3.51 Million-100.75%
2019 HK$0.47 B102.78%
2018 HK$0.23 B-63.92%
2017 HK$0.64 B
2016 N/A
2015 N/A-100%
2014 HK$0.10 B
2013 N/A-100%
2012 HK$0.35 M-82.3%
2011 HK$1.98 M-94.32%
2010 HK$34.96 M-77.82%
2009 HK$0.15 B447.25%
2008 HK$28.8 M-76.08%
2007 HK$0.12 B-17.17%
2006 HK$0.14 B2.02%
2005 HK$0.14 B93.13%
2004 HK$73.79 M275.27%
2003 HK$19.66 M139.02%
2002 HK$8.22 M168.34%
2001 HK$3.06 M-89.86%
2000 HK$30.24 M36.11%
1999 HK$22.21 M258.48%
1998 HK$6.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
MediciNova
MNOV
HK$1.04 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$20.88 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$6.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.95 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$1.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$717.34 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$3.10 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$452.49 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK